Two Cycles of ABVD Followed by Involved Field Radiotherapy with 20 Gray (Gy) Is the New Standard of Care in the Treatment of Patients with Early-Stage Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group (GHSG) HD10. Study Supported by the Deutsche Krebshilfe and in Part by the Competence Network Malignant Lymphoma.

• Engert, Andreas Department I of Internal Medicine, University of Cologne, Cologne, Germany, University of Cologne, Cologne, Germany,
• Diehl, Volker German Hodgkin Study Group (GHSG), University of Cologne, Cologne, Germany, University of Cologne, Cologne, Germany,
• Pluetschow, Annette German Hodgkin Study Group (GHSG), University of Cologne, Cologne, Germany, University of Cologne, Cologne, Germany,
• Eich, Hans T. Department of Radiation Oncology / German Hodgkin Study Group (GHSG), University of Cologne, Cologne/Germany, Germany,
• Herrmann, Richard Medical Oncology, University Hospital Basel, Basel, Switzerland,
• Doerken, Bernd Hematology Oncology, Charite Medical School, Berlin, Germany,
• Kanz, Lothar Department of Hematology, Oncology, Immunology, Rheumatology and Pneumology, University of Tuebingen Medical Center II, Tuebingen, Germany,
• Greil, Richard 3rd Med. Dept., Laboratory for Immunological & Molecular Cancer Research, University Hospital Salzburg, Salzburg, Austria,
• Markova, Jana Clinic Hematologia, Fakultne Nemocnice Kralovska Vinohrady, Prague, Czech Republic,
• Fuchs, Michael German Hodgkin Study Group (GHSG), University of Cologne, Cologne, Germany, University of Cologne, Cologne, Germany,
• Borchmann, Peter First Department of Internal Medicine, University of Cologne, Cologne, Germany,
• Mueller-Hermelink, Hans Konrad Department of Pathology, University of Wuerzburg, Wuerzburg, Germany,
• Mueller, Rolf Peter Department of Radiotherapy, University of Cologne, Cologne, Germany

Immunology

Cell Biology

Biochemistry

Hematology